NYSE
GRDN
Last Price
US $42.13
KEY FIGURES
MKT CAP
$2.7B
EPS
TTM
$0.84
PEG
TTM
0.24x
P/E
TTM
49.78x
P/S
TTM
1.85x
YIELD
0.00%
GROWTH
Revenue Y/Y
14.50%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $42.13
-45.53%
Default assumptions
EBITDA Multiple
Fair Value
Market $42.13
-70.02%
Default assumptions
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Guardian Pharmacy Services, Inc. cash flow to debt ratio of 270.03% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial stability - Healthy cash flow growth.
Guardian Pharmacy Services, Inc.'s free cash flow has increased 94.05% from $41.59M last year to $80.71M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Guardian Pharmacy Services, Inc.'s debt to equity ratio is 0.17, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Guardian Pharmacy Services, Inc.'s debt has decreased relative to shareholder equity from 0.26 last year to 0.17 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Guardian Pharmacy Services, Inc. has a net debt to EBITDA ratio of 0.00x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Guardian Pharmacy Services, Inc.'s interest coverage ratio of 128.94 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Guardian Pharmacy Services, Inc.'s profit margin has increased (-151.29%) in the last year from -7.11% to 3.64%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Guardian Pharmacy Services, Inc.'s short-term assets of $221.63M exceed its short-term liabilities of $160.70M
Increasing performance - ROA.
Guardian Pharmacy Services, Inc.'s return on assets of 12.43% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Guardian Pharmacy Services, Inc.'s return on equity of 27.21%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
Guardian Pharmacy Services, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Guardian Pharmacy Services, Inc. had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Guardian Pharmacy Services, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Guardian Pharmacy Services, Inc. has a free cash flow yield of 3.01%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Guardian Pharmacy Services, Inc.'s yearly earnings has increased -156.39% since last year from $-87.29M to $49.22M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Guardian Pharmacy Services, Inc.'s yearly revenue has increased 17.93% since last year from $1.23G to $1.45G, signaling increasing performance
Increasing performance - ROIC.
ROIC 20.71% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Guardian Pharmacy Services, Inc.'s 3-year revenue CAGR of 16.81% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Guardian Pharmacy Services, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Guardian Pharmacy Services, Inc. had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Guardian Pharmacy Services, Inc. is overvalued relative to its fair value price of 22.95 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Guardian Pharmacy Services, Inc. has an earnings yield of 1.98%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Guardian Pharmacy Services, Inc. is overvalued relative to its fair value price of 12.63 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Guardian Pharmacy Services, Inc. has an EV/EBITDA ratio of 25.91x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
Undervalued - PEG ratio value.
Guardian Pharmacy Services, Inc. has a PEG-ratio under 1 which is considered undervalued
Overvalued - P/B ratio.
Guardian Pharmacy Services, Inc. has a price-to-book ratio of 12.13x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Undervalued - P/S ratio.
Guardian Pharmacy Services, Inc. has a price-to-sales ratio of 1.84x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
27.21%
Return on equity
ROIC: 20.71%
Valuation History
49.8X
Price to Earnings
EV/EBITDA: 25.9X
Cash flow
Profit margin
14.46%
(FY vs FY)
Cash flow Y/Y
12.76%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.